Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia☆

Eichhorst, B. ; Ghia, P. ; Niemann, C. U. ; Kater, A. P. ; Gregor, M. ; Hallek, M. ; Jerkeman, M. LU and Buske, C. (2024) In Annals of Oncology 35(9). p.762-768
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
BCL2 inhibitor, BTK inhibitor, chronic lymphocytic leukaemia, guideline update, ibrutinib–venetoclax, time-limited targeted therapy
in
Annals of Oncology
volume
35
issue
9
pages
7 pages
publisher
Oxford University Press
external identifiers
  • scopus:85199699993
  • pmid:38969011
ISSN
0923-7534
DOI
10.1016/j.annonc.2024.06.016
language
English
LU publication?
yes
id
15f5cc8b-8c6e-4faf-81ec-1892e4c4c4fb
date added to LUP
2024-12-02 11:27:09
date last changed
2025-07-15 18:37:11
@article{15f5cc8b-8c6e-4faf-81ec-1892e4c4c4fb,
  author       = {{Eichhorst, B. and Ghia, P. and Niemann, C. U. and Kater, A. P. and Gregor, M. and Hallek, M. and Jerkeman, M. and Buske, C.}},
  issn         = {{0923-7534}},
  keywords     = {{BCL2 inhibitor; BTK inhibitor; chronic lymphocytic leukaemia; guideline update; ibrutinib–venetoclax; time-limited targeted therapy}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{762--768}},
  publisher    = {{Oxford University Press}},
  series       = {{Annals of Oncology}},
  title        = {{ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia<sup>☆</sup>}},
  url          = {{http://dx.doi.org/10.1016/j.annonc.2024.06.016}},
  doi          = {{10.1016/j.annonc.2024.06.016}},
  volume       = {{35}},
  year         = {{2024}},
}